ARID1A and carcinoid tumor: In fact, although mutation rates of EIF1AX and ARID1A are in line with those of typical carcinoids, a higher prevalence of MEN1 mutations is observed in atypical carcinoids as compared with typical carcinoids, reaching 25%.